{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:24:59Z","timestamp":1761110699520,"version":"3.37.3"},"reference-count":22,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n          <jats:title>Introduction<\/jats:title>\n          <jats:p>Bupropion is an antidepressant approved for the treatment of major depressive disorder (MDD), seasonal affective disorder, and smoking cessation. Nausea, headache, tremor, and insomnia are well-known adverse effects of this medication. Less well-recognized adverse effects include delayed allergic reactions, which, in some cases, can appear 2 or more weeks after bupropion initiation.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Case Report<\/jats:title>\n          <jats:p>A 27-year-old male with recurrent MDD was referred for medication treatment at an outpatient mental health clinic and prescribed bupropion XL. On day 28 of treatment, he reported significant improvement in depressive symptoms and the development of itchiness and urticaria on his extremities and back. Bupropion was tapered over the course of 7 days, and he was given cetirizine 10 mg daily. He was transitioned to venlafaxine treatment and experienced complete resolution of hives and pruritus.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Discussion<\/jats:title>\n          <jats:p>Despite published reports on bupropion causing delayed hypersensitivity reactions, there remains limited clinical recognition of this side effect, and the risk of underrecognition may be greater when the onset of the reaction is more than 2 weeks after bupropion initiation.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Conclusion<\/jats:title>\n          <jats:p>Bupropion can cause delayed hypersensitivity reactions, including delayed pruritis and urticaria. The risk may be highest in males aged 17 to 40 years and those with a history of allergic reactions.<\/jats:p>\n        <\/jats:sec>","DOI":"10.9740\/mhc.2024.10.293","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:01:29Z","timestamp":1727740889000},"page":"293-297","source":"Crossref","is-referenced-by-count":1,"title":["Delayed allergic reaction from bupropion in a 27-year-old male with MDD: A case report and literature review"],"prefix":"10.9740","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6267-3062","authenticated-orcid":true,"given":"Ana","family":"Anghel","sequence":"first","affiliation":[{"name":"Bachelor of Science in Psychology, Boise State University, Boise, Idaho"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2247-1466","authenticated-orcid":true,"given":"G. Lucy","family":"Wilkening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"article-title":"Drug Allergy: Pathogenesis [Internet]","author":"Pichler","key":"i2168-9709-14-5-293-b01","unstructured":"Pichler\n              WJ.\n            \n          \n          Drug Allergy: Pathogenesis [Internet]. Pocatello (ID): UpToDate; [cited 2024 Jun 13]. Available from: https:\/\/www-uptodate-com.libpublic3.library.isu.edu\/contents\/drug-allergy-pathogenesis?search=types%20of%20allergic%20reactions&source=search_result&selectedTitle=3%7E150&usage_type=default&display_rank=3#references"},{"key":"i2168-9709-14-5-293-b02","series-title":"StatPearls","article-title":"Type I Hypersensitivity Reaction","author":"Abbas","year":"2023","unstructured":"Abbas\n              M,\n            \n            \n              Moussa\n              M,\n            \n            \n              Akel\n              H.\n            \n          \n          Type I Hypersensitivity Reaction. StatPearls. StatPearls Publishing; 2023."},{"key":"i2168-9709-14-5-293-b03","series-title":"Clin Pharacol Ther","first-page":"239","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","unstructured":"Naranjo\n              CA,\n            \n            \n              Busto\n              U,\n            \n            \n              Sellers\n              EM,\n            \n            \n              Sandor\n              P,\n            \n            \n              Ruiz\n              I,\n            \n            \n              Roberts\n              EA,\n            \n            et al.\n          \n          A method for estimating the probability of adverse drug reactions. Clin Pharacol Ther. 1981;30:239-45. DOI: 10.1038\/clpt.1981.154"},{"key":"i2168-9709-14-5-293-b04","series-title":"Cureus","first-page":"e18297","article-title":"Bupropion-associated delayed onset urticaria","volume":"13","author":"Gutierrez","year":"2021","unstructured":"Gutierrez\n              N,\n            \n            \n              Malik\n              S,\n            \n            \n              Cohen\n              PR,\n            \n            \n              Winn\n              AE.\n            \n          \n          Bupropion-associated delayed onset urticaria. Cureus. 2021;13:e18297. DOI: 10.7759\/cureus.18297"},{"key":"i2168-9709-14-5-293-b05","series-title":"Prim Care Companion CNS Disord","first-page":"19l02508","article-title":"Delayed onset of bupropion-induced urticaria","volume":"22","author":"Puri","year":"2020","unstructured":"Puri\n              S,\n            \n            \n              Coplan\n              BM,\n            \n            \n              McGuire\n              PR.\n            \n          \n          Delayed onset of bupropion-induced urticaria. Prim Care Companion CNS Disord. 2020;22:19l02508. DOI: 10.4088\/PCC.19l02508"},{"key":"i2168-9709-14-5-293-b06","series-title":"Med J Aust","first-page":"650","article-title":"Bupropion-induced hypersensitivity reactions","volume":"174","author":"Benson","year":"2001","unstructured":"Benson\n              E.\n            \n          \n          Bupropion-induced hypersensitivity reactions. Med J Aust. 2001;174:650-1. DOI: 10.5694\/j.1326-5377.2001.tb143479.x11480688"},{"key":"i2168-9709-14-5-293-b07","series-title":"PLoS One","first-page":"e80064","article-title":"Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study","volume":"8","author":"Hu","year":"2013","unstructured":"Hu\n              LY,\n            \n            \n              Liu\n              CJ,\n            \n            \n              Lu\n              T,\n            \n            \n              Hu\n              T-M,\n            \n            \n              Tsai\n              C-F,\n            \n            \n              Hu\n              Y-W,\n            \n            et al.\n          \n          Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study. PLoS One. 2013;8:e80064. DOI: 10.1371\/journal.pone.0080064"},{"key":"i2168-9709-14-5-293-b08","series-title":"Mayo Clin Proc","first-page":"664","article-title":"Bupropion-induced erythema multiforme","volume":"76","author":"Lineberry","year":"2001","unstructured":"Lineberry\n              TW,\n            \n            \n              Peters\n              GE\n              Jr,\n            \n            \n              Bostwick\n              JM.\n            \n          \n          Bupropion-induced erythema multiforme. Mayo Clin Proc. 2001;76:664-6. DOI: 10.5021\/ad.2015.27.3.334"},{"key":"i2168-9709-14-5-293-b09","series-title":"Am J Health Syst Pharm","first-page":"1627","article-title":"Bupropion-induced angioedema","volume":"65","author":"Tackett","year":"2008","unstructured":"Tackett\n              AE,\n            \n            \n              Smith\n              KM.\n            \n          \n          Bupropion-induced angioedema. Am J Health Syst Pharm. 2008;65:1627-30. DOI: 10.2146\/ajhp070575"},{"key":"i2168-9709-14-5-293-b10","series-title":"Br J Dermatol","first-page":"660","article-title":"Bupropion and generalized acute urticaria: a further case","volume":"149","author":"Loo","year":"2003","unstructured":"Loo\n              WJ,\n            \n            \n              Alexandroff\n              A,\n            \n            \n              Flanagan\n              N.\n            \n          \n          Bupropion and generalized acute urticaria: a further case. Br J Dermatol. 2003;149:660. DOI: 10.1046\/j.1365-2133.2003.05509.x"},{"key":"i2168-9709-14-5-293-b11","series-title":"Prim Care Companion CNS Disord","article-title":"Urticaria and angioedema associated with bupropion: three cases","volume":"18","author":"Tuman","year":"2016","unstructured":"Tuman\n              TC,\n            \n            \n              Tuman\n              BA,\n            \n            \n              G\u00f6ks\u00fcg\u00fcr\n              N,\n            \n            \n              Kayka\n              N,\n            \n            \n              Y\u0131ld\u0131r\u0131m\n              O.\n            \n          \n          Urticaria and angioedema associated with bupropion: three cases. Prim Care Companion CNS Disord. 2016;18. DOI: 10.4088\/PCC.15l01916"},{"key":"i2168-9709-14-5-293-b12","series-title":"J Emerg Med","first-page":"e111-3","article-title":"Acute generalized erythrodermic pustular psoriasis associated with bupropion\/naltrexone (Contrave\u00ae)","volume":"52","author":"Singh","year":"2017","unstructured":"Singh\n              PA,\n            \n            \n              Cassel\n              KP,\n            \n            \n              Moscati\n              RM,\n            \n            \n              Eckersley\n              D.\n            \n          \n          Acute generalized erythrodermic pustular psoriasis associated with bupropion\/naltrexone (Contrave\u00ae). J Emerg Med. 2017;52:e111-3. DOI: 10.1016\/j.jemermed.2016.11.034"},{"key":"i2168-9709-14-5-293-b13","series-title":"Ann Emerg Med","first-page":"576","article-title":"Young woman with diffuse pustular rash","volume":"67","author":"Thurman","year":"2016","unstructured":"Thurman\n              RJ,\n            \n            \n              Hadley\n              ED\n              3rd.\n            \n          \n          Young woman with diffuse pustular rash. Ann Emerg Med. 2016;67:576-87. DOI: 10.1016\/j.annemergmed.2015.11.001"},{"key":"i2168-9709-14-5-293-b14","series-title":"Cureus","first-page":"e36158","article-title":"Bupropion-induced delayed hypersensitivity serum sickness-like reaction","volume":"15","author":"Cartwright","year":"2023","unstructured":"Cartwright\n              AM,\n            \n            \n              Shaw\n              JT,\n            \n            \n              Traiger\n              D.\n            \n          \n          Bupropion-induced delayed hypersensitivity serum sickness-like reaction. Cureus. 2023;15:e36158. DOI: 10.7759\/cureus.36158"},{"issue":"2","key":"i2168-9709-14-5-293-b15","series-title":"J Cutan Pathol","first-page":"177","article-title":"Serum sickness-like drug reaction: two cases with a neutrophilic urticarial pattern","volume":"44","author":"Nguyen","year":"2017","unstructured":"Nguyen\n              CV,\n            \n            \n              Miller\n              DD.\n            \n          \n          Serum sickness-like drug reaction: two cases with a neutrophilic urticarial pattern. J Cutan Pathol. 2017;44(2):177-82. DOI: 10.1111\/cup.12863"},{"key":"i2168-9709-14-5-293-b16","series-title":"Drug Saf","first-page":"1017","article-title":"Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004","volume":"31","author":"Beyens","year":"2008","unstructured":"Beyens\n              MN,\n            \n            \n              Guy\n              C,\n            \n            \n              Mounier\n              G,\n            \n            \n              Laporte\n              S,\n            \n            \n              Ollagnier\n              M.\n            \n          \n          Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008;31:1017-26. DOI: 10.2165\/00002018-200831110-00006"},{"key":"i2168-9709-14-5-293-b17","series-title":"Contact Dermatitis","first-page":"456","article-title":"Patch test-proven delayed-type hypersensitivity from naltrexone\/bupropion possibly eliciting psoriasis","volume":"85","author":"Caldas","year":"2021","unstructured":"Caldas\n              R,\n            \n            \n              Campos-Lopes\n              S,\n            \n            \n              Guimar\u00e3es\n              MJ,\n            \n            \n              Areal\n              J,\n            \n            \n              Alves\n              M,\n            \n            \n              Pereira\n              T.\n            \n          \n          Patch test-proven delayed-type hypersensitivity from naltrexone\/bupropion possibly eliciting psoriasis. Contact Dermatitis. 2021;85:456-8. DOI: 10.1111\/cod.13875"},{"issue":"12","key":"i2168-9709-14-5-293-b18","series-title":"Hum Exp Toxicol","first-page":"1294","article-title":"Pityriasis rosea-like drug eruption due to bupropion: a case report","volume":"33","author":"Polat","year":"2014","unstructured":"Polat\n              M,\n            \n            \n              Uzun\n              \u00d6,\n            \n            \n              \u00d6rs\n              I,\n            \n            \n              Boran\n              \u00c7.\n            \n          \n          Pityriasis rosea-like drug eruption due to bupropion: a case report. Hum Exp Toxicol. 2014;33(12):1294-6. DOI: 10.1177\/0960327113478444"},{"issue":"8","key":"i2168-9709-14-5-293-b19","series-title":"J Drugs Dermatol","first-page":"1010","article-title":"A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation","volume":"9","author":"Surovik","year":"2010","unstructured":"Surovik\n              J,\n            \n            \n              Riddel\n              C,\n            \n            \n              Chon\n              SY.\n            \n          \n          A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. J Drugs Dermatol. 2010;9(8):1010-2. PMID: 20684153"},{"key":"i2168-9709-14-5-293-b20","series-title":"JAMA","first-page":"1817","article-title":"Serum sickness-like reaction with bupropion","volume":"282","author":"Peloso","year":"1999","unstructured":"Peloso\n              PM,\n            \n            \n              Baillie\n              C.\n            \n          \n          Serum sickness-like reaction with bupropion. JAMA. 1999;282:1817. DOI: 10.1001\/jama.282.19.1817"},{"key":"i2168-9709-14-5-293-b21","series-title":"Pharmacol Rev","first-page":"62","article-title":"Dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","unstructured":"Channer\n              B,\n            \n            \n              Matt\n              SM,\n            \n            \n              Nickoloff-Bybel\n              EA,\n            \n            \n              Pappa\n              V,\n            \n            \n              Agarwal\n              Y,\n            \n            \n              Wickman\n              J,\n            \n            et al.\n          \n          Dopamine, immunity, and disease. Pharmacol Rev. 2023;75:62-158. DOI: 10.1124\/pharmrev.122.000618"},{"key":"i2168-9709-14-5-293-b22","series-title":"J Thromb Haemost","first-page":"911","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster","year":"2009","unstructured":"Aster\n              RH,\n            \n            \n              Curtis\n              BR,\n            \n            \n              McFarland\n              JG,\n            \n            \n              Bougie\n              DW.\n            \n          \n          Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7:911-8. DOI: 10.1111\/j.1538-7836.2009.03360.x"}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/14\/5\/article-p293.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/mhc\/article-pdf\/14\/5\/293\/3432025\/i2168-9709-14-5-293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/14\/5\/article-p293.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/14\/5\/article-p293.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:02:58Z","timestamp":1740268978000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/14\/5\/article-p293.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":22,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2024.10.293","relation":{},"ISSN":["2168-9709"],"issn-type":[{"type":"electronic","value":"2168-9709"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}